# DOW Inc.: Form 10-Q for the period ended Sep 30, 2020

- Company: [DOW Inc.](/companies/dow.md) (CIK 1751788)
- Form: 10-Q
- Filed: 2020-10-23
- Accepted by EDGAR: Oct 23, 2020, 07:56 ET
- Period: 2020-09-30
- Accession: 0001751788-20-000034
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1751788/000175178820000034/dow-20200930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1751788/000175178820000034/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $9.71bn | us-gaap:Revenues |
| Revenue | 9 months, 2020-01-01 to 2020-09-30 | $27.84bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $8.37bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2020-01-01 to 2020-09-30 | $24.21bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $372.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $1.06bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | $43.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | $215.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$25.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$11.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-07-01 to 2020-09-30 | 740,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-01-01 to 2020-09-30 | 740,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $4.60bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-07-01 to 2020-09-30 | $287.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $955.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months, 2020-01-01 to 2020-09-30 | $125.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-09-30 | $4.55bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $17.79bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $59.95bn | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $10.21bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-09-30 | $17.05bn | us-gaap:LongTermDebt |
| Short-term borrowings | at 2020-09-30 | $329.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-09-30 | $12.35bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-09-30 | 741,751,762 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 99,320 characters.

On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the “Company”), owning all of the outstanding common shares of TDCC. For filings related to the period commencing April 1, 2019 and thereafter, TDCC was deemed the predecessor to Dow Inc., and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted.

The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and E. I. du Pont de Nemours and Company and its consolidated subsidiaries (“Historical DuPont”) each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business.

As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and no longer consolidates Dow and its consolidated subsidiaries into its financial results. The consolidated financial results of Dow for all periods presented reflect the distribution of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) as discontinued operations, as well as reflect the receipt of Historical DuPont’s ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business) (“ECP”) as a common control transaction from the closing of the Merger on August 31, 2017. See Note 3 to the Consolidated Financial Statements for additional information.

Throughout this Quarterly Report on Form 10-Q, unless otherwise indicated, amounts and activity are presented on a continuing operations basis.

Except as otherwise indicated by the context, the terms "Union Carbide" means Union Carbide Corporation, and "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.

### Items Affecting Comparability of Financial Results

As a result of the separation from DowDuPont, pro forma net sales and pro forma Operating EBIT are provided in this section, which were based on the consolidated financial statements of TDCC, adjusted to give effect to the separation from DowDuPont as if it had been consummated on January 1, 2017. For the nine months ended September 30, 2019, pro forma adjustments have been made for (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva, Inc. ("Corteva") in connection with the separation, which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont, and (2) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs). These adjustments impacted the consolidated results as well as the reportable segments. For further information on the unaudited pro forma financial information, please refer to the Company's Current Report on Form 8-K dated June 3, 2019.

### STATEMENT ON COVID-19, OIL PRICE VOLATILITY AND FOURTH QUARTER OUTLOOK

#### Overview of Dow’s Response to COVID-19

The pandemic caused by coronavirus disease 2019 ("COVID-19") has impacted all geographic regions where Dow products are produced and sold. Financial markets were volatile towards the end of the first quarter and early in the second quarter of 2020, primarily due to uncertainty with respect to the severity and duration of the pandemic, coupled with fluctuations in crude oil prices due in part to the global spread of COVID-19. As the second quarter progressed, crude oil prices increased, driven by improved supply/demand fundamentals and those conditions continued in the third quarter. Financial markets also continued a gradual recovery in the third quarter of 2020.

The global, regional and local spread of COVID-19 resulted in significant global mitigation measures, including government-directed quarantines, social distancing and shelter-in-place mandates, travel restrictions and/or bans, and restricted access to certain corporate facilities and manufacturing sites. Most of the Company’s manufacturing facilities have been designated essential operations by local governments. As a result, nearly all of the Company’s manufacturing sites and facilities continue to operate and are doing so safely, having implemented social distancing and enhanced health, safety and sanitization measures as directed by Dow's regional Crisis Management Teams (“CMTs”). The CMTs continue to work closely with site leadership and are adjusting alert levels as warranted on a site by site basis. In the second quarter of 2020, the CMTs initiated implementation of the Company’s comprehensive Return to Workplace plan that is tailored for each site and includes a number of health and safety measures to be followed in a gradual and phased approach. Employees in Europe, Middle East, Africa, and India ("EMEAI") and Asia Pacific returned to the workplace throughout the third quarter of 2020, while in the U.S. & Canada employees are returning to the workplace at a slower rate. Latin America remains in an early phase and has not yet implemented return to workplace plans. Many sites in the U.S. & Canada are expected to increase returns to the workplace in the fourth quarter of 2020 as the Company continues its phased regional approach. At the time of this filing, approximately half of Dow’s global workforce is working remotely. The Company continues to encourage its workforce to follow safety measures when away from work to help prevent community spread of COVID-19.

Dow’s materials science expertise and production capabilities are used to develop some of the most vital hygiene and medical products and technologies to fight the COVID-19 pandemic, such as disinfectants, sanitizers, cleansers, plastics used in the production of disposable personal protective equipment for medical professionals, and memory foam for hospital beds. The Company has continued to look for ways to contribute time, talent and materials science expertise to help fight and combat the pandemic while creating some new opportunities for innovation and business. Dow’s contributions to fighting the COVID-19 pandemic include:

- The Company collaborated with nine key partners across a myriad of industries to develop and donate 100,000 isolation gowns to help equip frontline workers in Texas, Louisiana and Mexico.
- Dow, Whirlpool Corporation and Reynolds Consumer Products jointly developed a powered, air-purifying respirator which takes the place of a traditional medical face mask and face shield.
- Dow developed and shared an open source design for a simplified face shield and donated 100,000 face shields to hospitals in Michigan.
- Five Dow sites in the United States, Europe and Latin America produced more than 200 metric tons of hand sanitizer, equivalent to more than 880,000 eight-ounce bottles, which were primarily donated to local health systems and government agencies.
- The Company committed $3 million to aid COVID-19 relief efforts, with donations going towards global relief organizations, as well as non-profits in communities where Dow operates.

During this public health crisis, the Company is focused on the health and safety of its employees, contractors, customers and suppliers around the world and maintaining safe and reliable operations of its manufacturing sites. Although supply disruptions and related logistical issues have posed challenges across all modes of transportation, the Company’s manufacturing sites have continued to operate during the COVID-19 pandemic, with no significant impact to manufacturing whether through shutdowns or shortages in labor, raw materials or personal protective equipment. Supply chain and logistical challenges are expected to continue to ease through the remainder of 2020, absent significant impacts from COVID-19 infection resurgences.

The Company continues to maintain a strong financial position and build further liquidity in the midst of the economic recession triggered by the COVID-19 pandemic. The Company started 2020 with significant committed liquidity facilities. As markets became more volatile and uncertain during the first quarter of 2020, the Company took proactive measures to further bolster liquidity by drawing down certain uncommitted credit facilities, which were subsequently repaid in the second quarter of 2020, and partially monetizing investments in company-owned life insurance policies. At September 30, 2020, the Company had cash and committed and available forms of liquidity in excess of $13.5 billion. The Company also has no substantive long-term debt maturities until the second half of 2024.

The Company has taken proactive actions to electively focus on cash and maintain financial strength with a continued emphasis on safe, reliable operations and disciplined capital allocation. These actions include:

- Further reducing the 2020 capital expenditure target to $1.25 billion; implementing structural cost interventions designed to reduce operating expenses by a total of $500 million in 2020; and targeting to unlock another $500 million from working capital.
- Temporarily suspending share repurchases.
- Delaying planned maintenance turnaround spending, where appropriate, without compromising safety or the ability to serve customer needs.
- Temporarily idled select manufacturing facilities to balance production to demand across markets more severely affected by restrained economic activity. This included the idling of three polyethylene production units and two elastomers units; running Dow's polyurethanes assets, including propylene oxide and methylene diphenyl diisocyanate, at reduced operating rates; reducing siloxanes operating rates globally and extending a planned maintenance turnaround at a silicones production unit in Zhangjiagang, China. All of these assets returned to more normalized operating rates in the third quarter.
- Implementing a restructuring program ("2020 Restructuring Program"), which was approved by the Board of Directors ("Board") of Dow Inc. on September 29, 2020, targeting more than $300 million in annualized Operating EBITDA1 benefit by the end of 2021. This program includes a 6 percent reduction in Dow’s global workforce costs as well as actions to rationalize the Company's manufacturing assets, including asset write-down and write-off charges, related contract termination fees and environmental remediation costs. See Note 6 to the Consolidated Financial Statements for additional information.

#### Review of 2020 Financial Impacts from COVID-19 and Fourth Quarter Outlook

The Company's sales declined 15 percent in the first nine months of 2020 compared with the same period last year, as the COVID-19 pandemic disrupted the global economy and supply/demand fundamentals. The most significant impact occurred in the first half of the year, with uneven recovery in the third quarter.

In the first six months of 2020, the Company's sales declined 18 percent compared with the same period last year, with the most significant impact on demand in the second quarter of 2020. Strong demand in food packaging, health and hygiene, home care and pharma end-markets was more than offset by volume declines for products used in consumer durable good end-markets, including construction, furniture and bedding and automotive, with the most notable impacts in the Industrial Intermediates & Infrastructure and Performance Materials & Coatings operating segments. Demand for products used in consumer durable goods remained lower through the second quarter largely due to the delayed restart in these industries from May to June.

Local price declined in the first and second quarters of 2020, largely impacted by lower global energy prices. In March and April 2020, crude oil prices declined significantly, due in part to the COVID-19 pandemic, coupled with increased supply from oil producers. Crude oil prices increased in the latter half of the second quarter as supply/demand fundamentals improved, driving higher feedstock costs, which proved beneficial to product prices and margins in the third quarter of 2020.

In the third quarter of 2020, net sales increased 16 percent compared with the second quarter of 2020, due to increasing demand and higher local prices. Sales increased sequentially in all operating segments and geographic regions, reflecting improved demand trends in furniture and bedding, appliances, packaging, construction and automotive end-markets. Local price also increased sequentially, reflecting higher global energy prices and improved supply/demand fundamentals, with increases in all geographic regions. Local price increases were reported in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure, which more than offset declines in Performance Materials & Coatings. Operating rates increased from lows in the second quarter of 2020, as the Company raised rates to match demand trends as the global economic recovery gains traction. The Company's deliberate focus on structural cost reductions and prudent cash management resulted in sequentially higher margins and cash flow in the third quarter of 2020.

The Company expects net sales of $9.5 billion to $9.8 billion in the fourth quarter of 2020, with continued demand recovery offset by typical seasonality. Key value chains in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure are expected to remain strong heading into the fourth quarter, as demand in packaging end-markets continues to be resilient and durable good end-markets continue to rebound. Local price is expected to increase sequentially in all operating segments and all geographic regions, driven by improving supply/demand fundamentals and pricing initiatives. The Company expects the rebound from first half lows that benefited the third quarter results to continue, growing at a moderate pace through the fourth quarter, absent any significant second-wave pandemic impacts that could affect consumer purchasing patterns.

The Company enters the fourth quarter with sequential momentum and enhanced financial flexibility. While the third quarter rebound was significant, the recovery has been uneven across end-markets and the Company expects this will continue in the near term. As economic gains strengthen and broaden, Dow is prepared to capture significant upside opportunity. The Company will continue to focus on a disciplined approach to cash generation, capital allocation and structural cost improvements. The Company's proactive and agile approach to evolving market conditions combined with feedstock flexibility, geographic breadth and participation in diverse end-markets and technologies will enable Dow to continue to build on its performance. The Company remains confident that its decisive actions this year will continue to differentiate Dow in this environment.

1\. Operating EBITDA is a non-GAAP measure. Dow defines Operating EBITDA as earnings (i.e., "Income (loss) from continuing operations before income

taxes") before interest, depreciation and amortization, excluding the impact of significant items.

At the time of this filing, the ultimate severity and duration of the COVID-19 pandemic cannot be reasonably estimated. The COVID-19 pandemic has had and could continue to have a substantial negative impact on the Company’s results of operations, financial condition and cash flows. The effects of the COVID-19 pandemic in the first nine months of 2020 and the additional risks associated with these conditions are more fully discussed in this report in Part II, Item 1A, Risk Factors. The Company is actively monitoring for potential financial impacts from the COVID-19 pandemic and oil price volatility, including, but not limited to: gauging the financial health of its customers; assessing liquidity; evaluating the recoverability of its assets; enhancing cyber security monitoring; and evaluating ongoing appropriateness of its estimates.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. There have been no significant impacts to the Company's results of operations or financial position resulting from the CARES Act in the three and nine months ended September 30, 2020. The Company continues to assess the provisions and potential impacts of this legislation and expects to realize certain effects of the CARES Act in the fourth quarter of 2020. At this time the Company does not expect the CARES Act to have a significant impact on the provision for income taxes on continuing operations in 2020.

### OVERVIEW

The following is a summary of the results from continuing operations for the three months ended September 30, 2020:

- The Company reported net sales in the third quarter of 2020 of $9.7 billion, down 10 percent from $10.8 billion in the third quarter of 2019, with declines across all geographic regions and operating segments. The sales decline was primarily driven by local price declines.
- Local price decreased 9 percent compared with the same period last year, primarily in response to lower global energy prices, with declines in all geographic regions. Local price declined in Packaging & Specialty Plastics (down 12 percent), Industrial Intermediates & Infrastructure (down 7 percent) and Performance Materials & Coatings (down 6 percent).
- Volume decreased 1 percent compared with the third quarter of 2019. Packaging & Specialty Plastics volume was up 1 percent. Volume decreased in Industrial Intermediates & Infrastructure (down 3 percent) and Performance Materials & Coatings (down 5 percent). Volume increased in Latin America and EMEAI, was flat in Asia Pacific, and decreased in the U.S. & Canada.
- Restructuring and asset related charges - net were $617 million in the third quarter of 2020, primarily reflecting actions related to the 2020 Restructuring Program which was approved by Dow Inc.'s Board on September 29, 2020. As a result of these actions, the Company recorded pretax restructuring charges of $575 million, consisting of severance and related benefit costs of $297 million, asset write-downs and write-offs of $197 million and costs associated with exit and disposal activities of $81 million. Other impacts included asset impairment charges of $46 million and a favorable adjustment to a prior restructuring program.
- Integration and separation costs were $63 million in the third quarter of 2020, down from $164 million in the third quarter of 2019, reflecting the continued wind-down of business separation activities.
- Equity in earnings of nonconsolidated affiliates was $60 million in the third quarter of 2020, compared with equity losses of $44 million in the third quarter of 2019, driven by lower equity losses at Sadara Chemical Company ("Sadara") and higher equity earnings at the Thai joint ventures, which were partially offset by lower equity earnings at the Kuwait joint ventures.
- Sundry income (expense) - net for Dow Inc. and TDCC was income of $182 million and $181 million, respectively, in the third quarter of 2020, compared with income of $301 million and $284 million for Dow Inc. and TDCC, respectively, in the third quarter of 2019. The third quarter of 2020 included a $233 million gain related to the sale of rail infrastructure in the U.S. & Canada and a $63 million loss on the early extinguishment of debt.
- Net income (loss) available for Dow Inc. and TDCC common stockholder(s) was a loss of $25 million in the third quarter of 2020, compared with income of $333 million and $310 million for Dow Inc. and TDCC, respectively, in the third quarter of 2019. Earnings (loss) per share for Dow Inc. was a loss per share of $0.04 in the third quarter of 2020, compared with earnings per share of $0.45 in the third quarter of 2019.
- On August 13, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, which was paid on September 11, 2020, to shareholders of record as of August 31, 2020.
- Dow Inc. did not repurchase any of the Company's common stock in the third quarter of 2020.
- On August 13, 2020, Gaurdie Banister Jr., former President and CEO of Aera Energy LLC, an oil and gas exploration and production company jointly owned by Shell Oil Company and ExxonMobil Corporation, was elected to Dow Inc.'s Board.
- On August 26, 2020, TDCC announced the completion of a public offering of $2.0 billion aggregate principal amount of its notes. The notes included $850 million aggregate principal amount of 2.1 percent notes due 2030 and $1.15 billion aggregate principal amount of 3.6 percent notes due 2050 (together, the "Notes"). Net proceeds from the issuance of the Notes were used to repay indebtedness, including Dow Silicones' voluntary repayment of the $1.25 billion outstanding principal balance under a certain third party credit agreement ("Term Loan Facility"). In addition, proceeds from the Notes were used to fund cash tender offers for certain of TDCC's debt securities and certain debt securities of Union Carbide.
- On September 14, 2020, TDCC announced that it entered into a definitive agreement to divest certain U.S. Gulf Coast marine and terminal operations and assets for expected cash proceeds of $620 million. The assets are located at TDCC’s sites in Plaquemine and St. Charles, Louisiana, and Freeport, Texas. The transaction is expected to close in the fourth quarter of 2020, subject to customary regulatory approvals and other closing conditions.
- On September 15, 2020, the Company announced that John Sampson will rejoin Dow as Senior Vice President, Operations, Manufacturing and Engineering, succeeding Peter Holicki, who will retire in 2021 after more than 34 years of service with Dow.
- On September 30, 2020, TDCC completed the sale of rail infrastructure at six sites in the U.S. & Canada for cash proceeds of $315 million.

In addition to the highlights above, the following event occurred subsequent to the third quarter of 2020:

- On October 15, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on December 11, 2020, to shareholders of record as of November 30, 2020.

*In millions*

| Selected Financial Data - Dow Inc. | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $9,712 | $10,764 | $27,836 | $32,747 |
| Cost of sales ("COS") | $8,371 | $9,377 | $24,211 | $27,939 |
| Percent of net sales | 86.2% | 87.1% | 87.0% | 85.3% |
| R&D | $193 | $194 | $554 | $592 |
| Percent of net sales | 2.0% | 1.8% | 2.0% | 1.8% |
| SG&A | $372 | $388 | $1,063 | $1,258 |
| Percent of net sales | 3.8% | 3.6% | 3.8% | 3.8% |
| Effective tax rate | 102.4% | 20.6% | 84.3% | 37.5% |
| Net income (loss) available for common stockholders | $(25) | $333 | $(11) | $964 |

*In millions*

| Selected Financial Data - TDCC | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $9,712 | $10,764 | $27,836 | $32,747 |
| Cost of sales ("COS") | $8,371 | $9,377 | $24,209 | $27,938 |
| Percent of net sales | 86.2% | 87.1% | 87.0% | 85.3% |
| R&D | $193 | $194 | $554 | $592 |
| Percent of net sales | 2.0% | 1.8% | 2.0% | 1.8% |
| SG&A | $372 | $389 | $1,062 | $1,255 |
| Percent of net sales | 3.8% | 3.6% | 3.8% | 3.8% |
| Effective tax rate | 102.4% | 21.7% | 84.3% | 33.8% |
| Net income (loss) available for common stockholder | $(25) | $310 | $(11) | $1,068 |

59

### RESULTS OF OPERATIONS

### Net Sales

The following tables summarize net sales, pro forma net sales and sales variances by operating segment and geographic region from the prior year:

*In millions*

| Summary of Sales Results | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $9,712 | $10,764 | $27,836 | $32,747 |
| Pro forma net sales |  |  |  | $32,794 |

*Sales Variances by Operating Segment and Geographic Region - As Reported*

| Local Price & Product Mix Percentage change from prior year | Three Months Ended Sep 30, 2020 Currency | Volume | Total | Local Price & Product Mix | Nine Months Ended Sep 30, 2020 Currency | Volume | Portfolio & Other 1 | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Packaging & Specialty Plastics | (12)% | 1% | 1% | (10)% | (14)% | —% | —% | —% | (14)% |
| Industrial Intermediates & Infrastructure | (7) | 1 | (3) | (9) | (8) | — | (8) | — | (16) |
| Performance Materials & Coatings | (6) | — | (5) | (11) | (6) | (1) | (8) | 1 | (14) |
| Total | (9)% | —% | (1)% | (10)% | (11)% | —% | (4)% | —% | (15)% |
| Total, excluding the Hydrocarbons & Energy business | (6)% | —% | (2)% | (8)% | (9)% | 1% | (5)% | —% | (13)% |
| U.S. & Canada | (5)% | —% | (9)% | (14)% | (8)% | —% | (10)% | 1% | (17)% |
| EMEAI | (16) | 2 | 4 | (10) | (15) | — | (1) | — | (16) |
| Asia Pacific | (5) | — | — | (5) | (9) | — | — | — | (9) |
| Latin America | (9) | (1) | 6 | (4) | (11) | — | (2) | — | (13) |
| Total | (9)% | —% | (1)% | (10)% | (11)% | —% | (4)% | —% | (15)% |

1\. Portfolio & Other includes the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.

Net sales in the third quarter of 2020 were $9.7 billion, down 10 percent from $10.8 billion in the third quarter of 2019, with local price down 9 percent and volume down 1 percent. Net sales decreased in all geographic regions and operating segments, reflecting the impact of the COVID-19 pandemic on global economies and supply/demand fundamentals. Local price declined in all operating segments and all geographic regions, primarily due to lower global energy prices. Local price decreased in Packaging & Specialty Plastics (down 12 percent), Industrial Intermediates & Infrastructure (down 7 percent) and Performance Materials & Coatings (down 6 percent). Volume decreased in the U.S. & Canada, which more than offset increases in EMEAI and Latin America. Volume in Asia Pacific was flat. Volume increased in Packaging & Specialty Plastics (up 1 percent) and declined in Industrial Intermediates & Infrastructure (down 3 percent) and Performance Materials & Coatings (down 5 percent). Currency was flat compared with the same period last year. Excluding the Hydrocarbons & Energy business, sales declined 8 percent.

Net sales for the first nine months of 2020 were $27.8 billion, down 15 percent from $32.7 billion in the same period last year, with local price down 11 percent and volume down 4 percent. Net sales decreased in all geographic regions and operating segments. Local price decreased in all operating segments and in all geographic regions, primarily in response to lower global energy prices. Local price decreased in Packaging & Specialty Plastics (down 14 percent), Industrial Intermediates & Infrastructure (down 8 percent) and Performance Materials & Coatings (down 6 percent). Volume decreased 4 percent with declines in all geographic regions, except Asia Pacific which was flat. Volume was flat in Packaging & Specialty Plastics and decreased in Industrial Intermediates & Infrastructure and Performance Materials & Coatings (both down 8 percent). Currency was flat compared with the same period last year. Excluding the Hydrocarbons & Energy business, sales declined 13 percent.

*Sales Variances by Operating Segment and Geographic Region - Pro Forma Basis*

| Local Price & Product Mix Percentage change from prior year | Nine Months Ended Sep 30, 2020 Currency | Volume | Total |  |
| --- | ---: | ---: | ---: | ---: |
| Packaging & Specialty Plastics | (14)% | —% | —% | (14)% |
| Industrial Intermediates & Infrastructure | (8) | — | (8) | (16) |
| Performance Materials & Coatings | (6) | (1) | (7) | (14) |
| Total | (11)% | —% | (4)% | (15)% |
| Total, excluding the Hydrocarbons & Energy business | (9)% | —% | (5)% | (14)% |
| U.S. & Canada | (8)% | —% | (9)% | (17)% |
| EMEAI | (15) | — | (1) | (16) |
| Asia Pacific | (9) | (1) | — | (10) |
| Latin America | (11) | — | (2) | (13) |
| Total | (11)% | —% | (4)% | (15)% |

Net sales for the first nine months of 2020 were $27.8 billion, down 15 percent from pro forma net sales of $32.8 billion in the same period last year, with local price down 11 percent and volume down 4 percent. Net sales decreased in all geographic regions and operating segments. Local price decreased in all operating segments and in all geographic regions, primarily in response to lower global energy prices. Local price decreased in Packaging & Specialty Plastics (down 14 percent), Industrial Intermediates & Infrastructure (down 8 percent) and Performance Materials & Coatings (down 6 percent). Volume decreased 4 percent, with declines in all geographic regions, except Asia Pacific, which was flat. Volume was flat in Packaging & Specialty Plastics and decreased in Industrial Intermediates & Infrastructure (down 8 percent) and Performance Materials & Coatings (down 7 percent). Currency was flat compared with the same period last year. Excluding the Hydrocarbons & Energy business, sales declined 14 percent.

### Cost of Sales

COS was $8.4 billion in the third quarter of 2020 ($24.2 billion for the first nine months of 2020) down from $9.4 billion in the third quarter of 2019 ($27.9 billion in the first nine months of 2019), primarily due to lower feedstock and other raw material costs and decreased sales volume. The three and nine months ended September 30, 2019 included $399 million in environmental charges, which were partially offset by lower planned maintenance turnaround costs and a favorable adjustment to the warranty accrual of an exited business. COS as a percentage of net sales in the third quarter of 2020 was 86.2 percent (87.1 percent in the third quarter of 2019) and 87.0 percent for the first nine months of 2020 (85.3 percent for the first nine months of 2019).

### Research and Development Expenses

R&D expenses totaled $193 million in the third quarter of 2020, compared with $194 million in the third quarter of 2019. R&D expenses for the first nine months of 2020 were $554 million, down from $592 million in the first nine months of 2019. R&D expenses for the three and nine months ended September 30, 2020 decreased primarily due to cost reductions, which were partially offset by higher performance-based compensation costs.

### Selling, General and Administrative Expenses

#### Dow Inc.

SG&A expenses were $372 million in the third quarter of 2020, down from $388 million in the third quarter of 2019. For the first nine months of 2020, SG&A expenses were $1,063 million, down from $1,258 million in the first nine months of 2019. SG&A expenses for the three months ended September 30, 2020 decreased compared with the same period last year, primarily due to cost reductions which were partially offset by higher performance-based compensation costs. SG&A expenses in the third quarter of 2019 were favorably impacted by a recovery of a portion of legal costs related to the Nova Chemicals Corporation ("Nova") litigation award. In addition to the items disclosed above, SG&A expenses for the nine months ended September 30, 2020 were favorably impacted by the recovery of legal costs related to the Nova ethylene asset matter and the reversal of a bad debt reserve related to an arbitration judgment.

#### TDCC

SG&A expenses were $372 million in the third quarter of 2020, down from $389 million in the third quarter of 2019. For the first nine months of 2020, SG&A expenses were $1,062 million, down from $1,255 million in the first nine months of 2019.

### Amortization of Intangibles

Amortization of intangibles was $100 million in the third quarter of 2020 and 2019. In the first nine months of 2020, amortization of intangibles was $300 million, down from $320 million in the first nine months of 2019. See Note 11 to the Consolidated Financial Statements for additional information on intangible assets.

### Restructuring and Asset Related Charges - Net

#### 2020 Restructuring Program

On September 29, 2020, Dow Inc.'s Board approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the COVID-19 pandemic. The restructuring program is designed to reduce structural costs and enable the Company to further enhance competitiveness while the COVID-19 economic recovery gains traction. As a result of these actions, in the third quarter of 2020 the Company recorded pretax restructuring charges of $575 million, consisting of severance and related benefit costs of $297 million, asset write-downs and write-offs of $197 million and costs associated with exit and disposal activities of $81 million. These actions are expected to be substantially complete by the end of 2021.

#### DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the "Synergy Program") which was designed to integrate and optimize the organization following the Merger and in preparation for the business separations. The Company expects cash expenditures related to the Synergy Program to be substantially complete by the end of 2020.

For the three months ended September 30, 2020, the Company recorded a favorable adjustment to the Synergy Program related to severance and related benefit costs of $4 million. For the nine months ended September 30, 2020, the Company recorded pretax restructuring charges of $90 million for severance and related benefit costs under the Synergy Program.

For the three months ended September 30, 2019, the Company recorded pretax restructuring charges of $56 million, consisting of severance and related benefit costs of $46 million, asset write-downs and write-offs of $5 million and costs associated with exit and disposal activities of $5 million. For the nine months ended September 30, 2019, the Company recorded pretax restructuring charges of $259 million, consisting of severance and related benefit costs of $123 million, asset write-downs and write-offs of $110 million and costs associated with exit and disposal activities of $26 million.

#### Asset Related Charges

Pretax impairment charges for the three months ended September 30, 2020 included a $15 million charge for the write-down of a non-manufacturing asset and the write-off of a capital project (related to Performance Materials & Coatings), a $24 million charge associated with the write-down of certain corporate leased equipment (related to Corporate) and additional pretax impairment charges of $7 million related to capital additions made to a bio-ethanol manufacturing facility in Santa Vitoria, Minas Gerais, Brazil, which was impaired in 2017 ($19 million for the nine months ended September 30, 2020, related to Packaging & Specialty Plastics). On September 29, 2020, the Company divested the bio-ethanol manufacturing facility. Pretax impairment charges for the three and nine months ended September 30, 2019 primarily related to the bio-ethanol manufacturing facility and were $16 million and $34 million, respectively (related to Packaging & Specialty Plastics and Performance Materials & Coatings).

In the third quarter of 2019, the Company recognized a pretax impairment charge of $75 million related to the then-planned divestiture of its acetone derivatives business, which closed on November 1, 2019. The charge was included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($24 million) and Corporate ($51 million).

### Integration and Separation Costs

Integration and separation costs, which reflect costs related to business separation activities, were $63 million in the third quarter of 2020, down from $164 million in the third quarter of 2019. In the first nine months of 2020, integration and separation costs were $174 million, down from $964 million and $940 million for Dow Inc. and TDCC, respectively, in the first nine months of 2019. Further decreases in integration and separation costs are expected as business separation activities are completed by the end of the year. Integration and separation costs are related to Corporate.

### Equity in Earnings (Losses) of Nonconsolidated Affiliates

The Company's share of equity in earnings of nonconsolidated affiliates was $60 million in the third quarter of 2020, up from losses of $44 million in the third quarter of 2019, primarily driven by lower equity losses at Sadara and higher equity earnings at the Thai joint ventures, which were partially offset by lower equity earnings at the Kuwait joint ventures. Equity in losses of nonconsolidated affiliates was $124 million in the first nine months of 2020, compared with losses of $73 million in the first nine months of 2019, primarily due to lower equity earnings from the Kuwait joint ventures, which were partially offset by lower equity losses from Sadara. See Note 10 to the Consolidated Financial Statements for additional information.

### Sundry Income (Expense) – Net

Sundry income (expense) – net includes a variety of income and expense items such as foreign currency exchange gains and losses, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters.

#### TDCC

For the three months ended September 30, 2020, "Sundry income (expense) - net" was income of $181 million compared with income of $284 million for the three months ended September 30, 2019. The third quarter of 2020 included a $233 million gain related to the sale of rail infrastructure in the U.S. & Canada (related to Packaging & Specialty Plastics and Corporate) and non-operating pension and postretirement benefit plan credits. This was partially offset by a $63 million loss on the early extinguishment of debt (related to Corporate), foreign exchange losses, and a $13 million loss related to the divestiture of a bio-ethanol manufacturing facility in Brazil (related to Packaging & Specialty Plastics). The third quarter of 2019 included foreign currency exchange gains and non-operating pension and postretirement benefit plan credits, as well as a net gain of $205 million related to litigation matters, which included a $170 million gain related to a legal settlement with Nova (related to Packaging & Specialty Plastics) and an $85 million gain related to an adjustment of the Dow Silicones' breast implant liability (related to Corporate), which were partially offset by a $50 million charge (net of indemnification of $37 million) related to the settlement of the Dow Silicones' commercial creditor matters (related to Corporate). For the nine months ended September 30, 2020, "Sundry income (expense) - net" was income of $150 million compared with income of $462 million for the nine months ended September 30, 2019. In addition to the items previously disclosed, "Sundry income (expense) - net" for the nine months ended September 30, 2020 included an $86 million loss on the early extinguishment of debt (related to Corporate) and a $6 million gain related to the Nova ethylene asset matter (related to Packaging & Specialty Plastics). The nine months ended September 30, 2019 included a $14 million gain on post-closing adjustments related to a previous divestiture, which was more than offset by a $44 million loss on the early extinguishment of debt (both related to Corporate). See Notes 7, 12, 13, 17 and 23 to the Consolidated Financial Statements for additional information.

#### Dow Inc.

For the three months ended September 30, 2020, "Sundry income (expense) - net" was income of $182 million compared with income of $301 million for the three months ended September 30, 2019. For the nine months ended September 30, 2020, "Sundry income (expense) - net" was income of $154 million compared with income of $369 million for the nine months ended September 30, 2019. In addition to the items previously disclosed under TDCC, "Sundry income (expense) - net" for the nine months ended September 30, 2019 included a $58 million loss on post-closing adjustments related to a previous divestiture and $52 million in charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution (both related to Corporate). See Notes 3, 7, 12, 13, 17 and 23 to the Consolidated Financial Statements for additional information.

### Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was $202 million in the third quarter of 2020, down from $233 million and $238 million for Dow Inc. and TDCC, respectively, in the third quarter of 2019. Interest expense and amortization of debt discount was $617 million in the first nine months of 2020, down from $711 million and $728 million for Dow Inc. and TDCC, respectively, in the first nine months of 2019. The decreases are primarily due to the redemption of long-term debt in 2019 and debt issuances at lower coupon rates in 2020.

### Provision for Income Taxes

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. The effective tax rate for the third quarter of 2020 for Dow Inc. and TDCC was 102.4 percent, compared with 20.6 percent and 21.7 percent for Dow Inc. and TDCC, respectively, for the third quarter of 2019. For the first nine months of 2020, the effective tax rate for Dow Inc. and TDCC was 84.3 percent, compared with 37.5 percent and 33.8 percent for Dow Inc. and TDCC, respectively, for the first nine months of 2019. The tax rate for Dow Inc. and TDCC in the third quarter and first nine months of 2020 was unfavorably impacted by equity losses and geographic mix of earnings, non-deductible restructuring costs and an increase in tax reserves and was favorably impacted by a capital loss resulting from the divestiture of a bio-ethanol manufacturing facility in Brazil. The tax rate for Dow Inc. and TDCC in the third quarter of 2019 was unfavorably impacted by geographic mix of earnings and non-deductible restructuring costs and was favorably impacted by litigation awards and amended prior year returns. The tax rate for the first nine months of 2019 was favorably impacted by tax benefits related to the issuance of stock-based compensation and deferred tax remeasurement in foreign jurisdictions and unfavorably impacted by tax impacts related to spin preparation activities.

### Income from Discontinued Operations, Net of Tax

Income from discontinued operations, net of tax was $445 million for the first nine months of 2019, related to the distribution of AgCo and SpecCo to DowDuPont as a result of the separation. See Note 3 to the Consolidated Financial Statements for additional information.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests from continuing operations was $24 million in the third quarter of 2020, up from $14 million in the third quarter of 2019. For the first nine months of 2020, net income attributable to noncontrolling interests from continuing operations was $51 million, compared with $61 million for the same period last year.

Net income attributable to noncontrolling interests from discontinued operations was $13 million for the first nine months of 2019, related to the distribution of AgCo and SpecCo to DowDuPont as a result of the separation. See Note 16 to the Consolidated Financial Statements for additional information.

### Net Income (Loss) Available for Common Stockholder(s)

#### Dow Inc.

Net income (loss) available for Dow Inc. common stockholders was a loss of $25 million, or $0.04 per share, in the third quarter of 2020, compared with income of $333 million, or $0.45 per share, in the third quarter of 2019. Net income (loss) available for Dow Inc. common stockholders was a loss of $11 million, or $0.02 per share, in the first nine months of 2020, compared with income of $964 million, or $1.29 per share, in the first nine months of 2019. See Note 8 to the Consolidated Financial Statements for details on Dow Inc.'s earnings per share calculations.

#### TDCC

Net income (loss) available for the TDCC common stockholder was a loss of $25 million in the third quarter of 2020, compared with income of $310 million in the third quarter of 2019. Net income (loss) available for the TDCC common stockholder was a loss of $11 million in the first nine months of 2020, compared with income of $1,068 million in the first nine months of 2019. Following the separation from DowDuPont, TDCC's common shares are owned solely by Dow Inc.

### SEGMENT RESULTS

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT (for the three and nine months ended September 30, 2020 and the three months ended September 30, 2019) and pro forma Operating EBIT (for the nine months ended September 30, 2019) as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income from continuing operations before income taxes") before interest, excluding the impact of significant items. The Company defines pro forma Operating EBIT as earnings (i.e., "Income from continuing operations before income taxes") before interest, plus pro forma adjustments, excluding the impact of significant items. Operating EBIT and pro forma Operating EBIT by segment include all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. The Company also presents pro forma net sales for the nine months ended September 30, 2019, as it is included in management's measure of segment performance and is regularly reviewed by the CODM. Pro forma net sales includes the impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation from DowDuPont which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont. See Note 23 to the Consolidated Financial Statements for reconciliations of these measures and a summary of the pro forma adjustments impacting segment measures for the nine months ended September 30, 2019.

### PACKAGING & SPECIALTY PLASTICS

Packaging & Specialty Plastics consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; automotive; and infrastructure. Ethylene is transferred to downstream derivative businesses at market-based prices, which are generally equivalent to prevailing market prices for large volume purchases. This segment also includes the results of The

Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

The Company is responsible for marketing a majority of Sadara products outside of the Middle East zone through the Company's established sales channels. As part of this arrangement, the Company purchases and sells Sadara products for a marketing fee.

*In millions*

| Packaging & Specialty Plastics | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $4,565 | $5,062 | $13,175 | $15,405 |
| Pro forma net sales |  |  |  | $15,405 |
| Operating EBIT | $647 | $798 | $1,545 |  |
| Pro forma Operating EBIT |  |  |  | $2,256 |
| Equity earnings | $71 | $23 | $96 | $135 |

| Packaging & Specialty Plastics Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2020 |
| --- | ---: | ---: |
| Local price & product mix | (12)% | (14)% |
| Currency | 1 | — |
| Volume | 1 | — |
| Total | (10)% | (14)% |
| Change in Pro Forma Net Sales from Prior Period due to: 1 |  |  |
| Local price & product mix |  | (14)% |
| Currency |  | — |
| Volume |  | — |
| Total |  | (14)% |

1\. As reported net sales for the nine months ended September 30, 2020 compared with pro forma net sales for the nine months ended September 30, 2019.

Packaging & Specialty Plastics net sales were $4,565 million in the third quarter of 2020, down 10 percent from net sales of $5,062 million in the third quarter of 2019, with local price down 12 percent, a favorable currency impact of 1 percent, primarily in EMEAI, and volume up 1 percent. Local price decreased in both businesses and across all geographic regions, driven by lower global energy prices. Local price declined in Hydrocarbons & Energy as prices for co-products are generally correlated to Brent crude oil prices, which declined 30 percent compared with the third quarter of 2019, as well as lower by-product prices due to weak end-market demand. Local price declined in Packaging and Specialty Plastics driven by lower polyethylene prices. Volume increased in Hydrocarbons & Energy, primarily in EMEAI and Latin America, more than offsetting decreases in the U.S. & Canada. Packaging and Specialty Plastics volume was flat as increased demand for flexible food and specialty packaging; infrastructure, consumer and transportation packaging; and health and hygiene applications was offset by lower catalyst licensing activity and hurricane-driven outages.

Operating EBIT was $647 million in the third quarter of 2020, down 19 percent from Operating EBIT of $798 million in the third quarter of 2019. Operating EBIT decreased primarily due to integrated margin compression, which more than offset targeted cost reductions and improved integrated olefin and aromatics margins at Sadara and the Thai joint ventures.

Packaging & Specialty Plastics net sales were $13,175 million in the first nine months of 2020, down 14 percent from net sales and pro forma net sales of $15,405 million in the first nine months of 2019, with local price down 14 percent and currency and volume flat. Local price decreased in both businesses and across all geographic regions, driven by reduced polyethylene prices and lower global energy prices. Local price declined in Hydrocarbons & Energy as prices for co-products are generally correlated to Brent crude oil prices, which declined 34 percent compared with the first nine months of 2019. Volume was flat in Hydrocarbons & Energy as increases in EMEAI were offset by declines in Asia Pacific, Latin America and the U.S. & Canada. Volume was flat in Packaging and Specialty Plastics as increases in flexible food and specialty packaging, industrial and consumer packaging and health and hygiene applications in Asia Pacific, Latin America and EMEAI were offset by reduced demand for functional polymers, primarily due to the COVID-19 pandemic, and lower catalyst licensing activity in the U.S. & Canada.

Operating EBIT was $1,545 million in the first nine months of 2020, down 32 percent from pro forma Operating EBIT of $2,256 million in the first nine months of 2019. Operating EBIT decreased primarily due to integrated margin compression in both businesses and reduced equity earnings at the Kuwait joint ventures. These declines more than offset lower global energy prices, cost reductions and decreased planned maintenance turnaround costs.

### INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE

Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & Construction Chemicals - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide and propylene oxide derivatives that are aligned to market segments as diverse as appliances, coatings, infrastructure and oil and gas. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider, offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others. This segment also includes a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

The Company is responsible for marketing a majority of Sadara products outside of the Middle East zone through the Company's established sales channels. As part of this arrangement, the Company purchases and sells Sadara products for a marketing fee.

*In millions*

| Industrial Intermediates & Infrastructure | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $3,058 | $3,365 | $8,520 | $10,187 |
| Pro forma net sales |  |  |  | $10,196 |
| Operating EBIT | $104 | $193 | $59 |  |
| Pro forma Operating EBIT |  |  |  | $624 |
| Equity losses | $(13) | $(70) | $(202) | $(196) |

| Industrial Intermediates & Infrastructure Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2020 |
| --- | ---: | ---: |
| Local price & product mix | (7)% | (8)% |
| Currency | 1 | — |
| Volume | (3) | (8) |
| Total | (9)% | (16)% |
| Change in Pro Forma Net Sales from Prior Period due to: 1 |  |  |
| Local price & product mix |  | (8)% |
| Currency |  | — |
| Volume |  | (8) |
| Total |  | (16)% |

1\. As reported net sales for the nine months ended September 30, 2020 compared with pro forma net sales for the nine months ended September 30, 2019.

Industrial Intermediates & Infrastructure net sales were $3,058 million in the third quarter of 2020, down 9 percent from $3,365 million in the third quarter of 2019, with local price down 7 percent, volume down 3 percent and a favorable currency impact of 1 percent. Local price decreased in both businesses and in all geographic regions, primarily due to lower global energy prices. Polyurethanes & Construction Chemicals volume was down 1 percent as demand recovery in furniture and bedding and appliances, was more than offset by decreased demand in automotive end-markets and impacts from the COVID-19 pandemic. Volume increases in EMEAI and Asia Pacific were more than offset by declines in the U.S. & Canada and Latin America, following broader macroeconomic recovery patterns from the COVID-19 pandemic. Volume decreased in Industrial Solutions as improved demand for products used in electronics and pharma applications was more than offset by declines in industrial and energy end-markets as a result of the COVID-19 pandemic. Industrial Solutions volume increased in EMEAI due to increased catalyst sales as well as improved demand for heat transfer fluids used in concentrated solar power applications which was more than offset by decreased volume in all other geographic regions.

Operating EBIT was $104 million in the third quarter of 2020, down 46 percent from Operating EBIT of $193 million in the third quarter of 2019. Operating EBIT decreased due to weaker demand and margin compression which was partially offset by cost reductions and lower equity losses from Sadara.

Industrial Intermediates & Infrastructure net sales were $8,520 million in the first nine months of 2020, down 16 percent from net sales of $10,187 million in the first nine months of 2019. Net sales decreased 16 percent compared with pro forma net sales of $10,196 million in the first nine months of 2019, with local price and volume both down 8 percent. Local price decreased in both businesses and in all geographic regions, primarily due to lower global energy prices and raw material costs. Weak demand for products used in consumer durable good end-markets, including construction, furniture and bedding, and automotive, drove volume declines in Polyurethanes & Construction Chemicals in all geographic regions, except Asia Pacific which was flat. Volume decreases in Industrial Solutions in the U.S. & Canada and Latin America were partially offset by increases in Asia Pacific and EMEAI. The volume decline in Industrial Solutions was due to weakened demand in industrial, energy and automotive end-markets partially offset by stronger demand for products used in electronics, agriculture and pharma applications.

Operating EBIT was $59 million in the first nine months of 2020, down 91 percent compared with pro forma Operating EBIT of $624 million in the first nine months of 2019. Operating EBIT decreased due to lower demand and margin compression, which was partially offset by cost reductions and lower planned maintenance turnaround costs.

### PERFORMANCE MATERIALS & COATINGS

Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

*In millions*

| Performance Materials & Coatings | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $2,002 | $2,250 | $5,922 | $6,888 |
| Pro forma net sales |  |  |  | $6,926 |
| Operating EBIT | $75 | $200 | $264 |  |
| Pro forma Operating EBIT |  |  |  | $685 |
| Equity earnings | $1 | $2 | $4 | $3 |

| Performance Materials & Coatings Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2020 |
| --- | ---: | ---: |
| Local price & product mix | (6)% | (6)% |
| Currency | — | (1) |
| Volume | (5) | (8) |
| Portfolio & other | — | 1 |
| Total | (11)% | (14)% |
| Change in Pro Forma Net Sales from Prior Period due to: 1 |  |  |
| Local price & product mix |  | (6)% |
| Currency |  | (1) |
| Volume |  | (7) |
| Total |  | (14)% |

1\. As reported net sales for the nine months ended September 30, 2020 compared with pro forma net sales for the nine months ended September 30, 2019.

Performance Materials & Coatings net sales were $2,002 million in the third quarter of 2020, down 11 percent from net sales of $2,250 million in the third quarter of 2019, with local price down 6 percent, volume down 5 percent and currency flat. Local price decreased in both businesses and all geographic regions. Local price declined in Consumer Solutions primarily due to excess market supply of siloxanes. Local price decreased in Coatings & Performance Monomers due to weaker supply/demand fundamentals in monomers. Volume declined across all geographic regions, except Latin America, reflecting the impact from the COVID-19 pandemic. Consumer Solutions volume decreased as growth in home care applications was more than offset by lower demand for products used in automotive and construction end-markets, and high-end personal care applications. Volume increased in Coatings & Performance Monomers primarily driven by higher demand for architectural coatings as residential construction end-market dynamics improved and consumers continued do-it-yourself projects at home. Volume in Coatings & Performance Monomers increased in all geographic regions, except the U.S. & Canada which was flat due to lower demand for monomers used in oil and gas applications.

Operating EBIT was $75 million in the third quarter of 2020, down 63 percent from Operating EBIT of $200 million in the third quarter of 2019. Operating EBIT decreased, primarily driven by margin compression in siloxanes and lower demand due to the COVID-19 pandemic.

Performance Materials & Coatings net sales were $5,922 million in the first nine months of 2020, down 14 percent from net sales of $6,888 million in the first nine months of 2019. Net sales decreased 14 percent compared with pro forma net sales of $6,926 million in the first nine months of 2019, with volume down 7 percent, local price down 6 percent, and an unfavorable currency impact of 1 percent. Volume declined in both businesses. Consumer Solutions volume decreased due to lower demand in EMEAI, Asia Pacific and the U.S. & Canada, reflecting the impact of the COVID-19 pandemic, which was partially offset by demand growth in upstream siloxanes in Latin America. Coatings & Performance Monomers volume decreased in EMEAI and Asia Pacific, primarily due to the impact of the COVID-19 pandemic, which was partially offset by strong demand for home improvement applications in the U.S. & Canada and methacrylates in Latin America and EMEAI. Local price decreased in both businesses and all geographic regions. Consumer Solutions local price declined primarily in upstream siloxanes due to weak supply/demand fundamentals. Local price decreased in Coatings & Performance Monomers in response to lower feedstock and other raw material costs.

Operating EBIT was $264 million in the first nine months of 2020, down 61 percent from pro forma Operating EBIT of $685 million in the first nine months of 2019. Operating EBIT decreased primarily due to margin compression in siloxanes and lower demand as a result of the COVID-19 pandemic.

### CORPORATE

Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, etc.); non-business aligned joint ventures; non-business aligned litigation expenses; and discontinued or non-aligned businesses.

*In millions*

| Corporate | Three Months Ended Sep 30, 2020 | Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $87 | $87 | $219 | $267 |
| Pro forma net sales |  |  |  | $267 |
| Operating EBIT | $(65) | $(74) | $(207) |  |
| Pro forma Operating EBIT |  |  |  | $(246) |
| Equity earnings (losses) | $1 | $1 | $(22) | $(15) |

Net sales for Corporate, which primarily relate to the Company's insurance operations, were $87 million in the third quarter of 2020 and 2019. Net sales were $219 million in the first nine months of 2020, down from net sales and pro forma net sales of $267 million in the first nine months of 2019.

Operating EBIT was a loss of $65 million in the third quarter of 2020, compared with a loss of $74 million in the third quarter of 2019. Operating EBIT was a loss of $207 million in the first nine months of 2020, compared with a pro forma Operating EBIT loss of $246 million in the first nine months of 2019. Operating EBIT improved primarily due to cost reductions and stranded cost removal throughout 2019.

### CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents of $4,549 million at September 30, 2020 and $2,367 million at December 31, 2019, of which $1,547 million at September 30, 2020 and $986 million at December 31, 2019 was held by subsidiaries in foreign countries, including U.S. territories. For each of its foreign subsidiaries, Dow makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the United States, which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. During 2020, Dow has repatriated and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations or separation activities; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

The Company's cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:

*In millions*

| Cash Flow Summary Cash provided by (used for): | Dow Inc. Nine Months Ended Sep 30, 2020 | Sep 30, 2019 | TDCC Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Operating activities - continuing operations | $4,596 | $3,793 | $4,604 | $3,766 |
| Operating activities - discontinued operations | — | 187 | — | 371 |
| Operating activities | 4,596 | 3,980 | 4,604 | 4,137 |
| Investing activities - continuing operations | (616) | (1,561) | (616) | (1,561) |
| Investing activities - discontinued operations | — | (34) | — | (34) |
| Investing activities | (616) | (1,595) | (616) | (1,595) |
| Financing activities - continuing operations | (1,809) | (2,238) | (1,817) | (2,395) |
| Financing activities - discontinued operations | — | (18) | — | (18) |
| Financing activities | (1,809) | (2,256) | (1,817) | (2,413) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 4 | (54) | 4 | (54) |
| Summary |  |  |  |  |
| Increase in cash, cash equivalents and restricted cash | 2,175 | 75 | 2,175 | 75 |
| Cash, cash equivalents and restricted cash at beginning of period | 2,380 | 2,764 | 2,380 | 2,764 |
| Cash, cash equivalents and restricted cash at end of period | $4,555 | $2,839 | $4,555 | $2,839 |
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 6 | 16 | 6 | 16 |
| Cash and cash equivalents at end of period | $4,549 | $2,823 | $4,549 | $2,823 |

#### Cash Flows from Operating Activities

Cash provided by operating activities from continuing operations increased in the first nine months of 2020 compared with the first nine months of 2019. The improvement was primarily due to an increase in cash earnings, which was largely driven by a decrease in integration and separation costs. Also contributing to the improvement from prior year was a decrease in performance-based compensation payments, a cash receipt for the refund of withholding tax related to the Nova ethylene asset matter and an increase in advance payments from customers, which were partially offset by a decrease in dividends received from nonconsolidated affiliates and a reduction in cash generated from working capital.

*In millions*

| Net Working Capital | Dow Inc. Sep 30, 2020 | Dec 31, 2019 | TDCC Sep 30, 2020 | Dec 31, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Current assets | $17,789 | $16,815 | $17,715 | $16,733 |
| Current liabilities | 10,207 | 10,679 | 9,583 | 10,150 |
| Net working capital | $7,582 | $6,136 | $8,132 | $6,583 |
| Current ratio | 1.74:1 | 1.57:1 | 1.85:1 | 1.65:1 |

69

| Working Capital Metrics | Three Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: |
| Days sales outstanding in receivables 1 | 43 | 46 |
| Days sales in inventory 2 | 63 | 65 |
| Days payables outstanding 3 | 58 | 63 |

1\. The decrease in days sales outstanding in receivables was primarily due to a decrease in average accounts receivable, which more than offset a decrease in net sales.

2\. The decrease in days sales in inventory was primarily due to a decrease in average inventory, which more than offset a decrease in COS.

3\. The decrease in days payables outstanding was primarily due to a decrease in average accounts payable and an increase in the change in inventory, which more than offset a decrease in COS.

Cash used for operating activities from discontinued operations in the first nine months of 2020 decreased compared with cash provided by operating activities from discontinued operations in the first nine months of 2019 due to the separation of AgCo and SpecCo on April 1, 2019. See Note 3 to the Consolidated Financial Statements for additional information.

#### Cash Flows from Investing Activities

Cash used for investing activities from continuing operations in the first nine months of 2020 was primarily for capital expenditures, purchases of investments, investments in and loans to nonconsolidated affiliates (related to Sadara) and acquisitions of property and businesses, which were partially offset by proceeds from sales and maturities of investments, which included partial monetization of the Company's investment in company-owned life insurance policies, and proceeds from sales of property and businesses. Cash used for investing activities from continuing operations in the first nine months of 2019 was primarily for capital expenditures, purchases of investments and investments in and loans to nonconsolidated affiliates (primarily with Sadara), which were partially offset by proceeds from sales and maturities of investments.

The Company's capital expenditures, including capital expenditures of consolidated variable interest entities, were $955 million in the first nine months of 2020, compared with $1,384 million in the first nine months of 2019. In April 2020, the Company reduced its capital expenditure target and expects full year capital spending in 2020 to be approximately $1.25 billion. The Company will adjust its spending through the year as economic conditions develop.

In the first nine months of 2020, the Company loaned $280 million to Sadara. The Company expects to loan Sadara up to $400 million in 2020. Due to the potential for Dow to continue providing financial support to Sadara, the Company will continue to recognize its share of equity losses reported by Sadara.

Cash used in investing activities from discontinued operations in the first nine months of 2019 was primarily for capital expenditures, partially offset by proceeds from the sale of property and businesses and proceeds from sales of ownership interests in nonconsolidated affiliates.

#### Cash Flows from Financing Activities

Cash used for financing activities from continuing operations in the first nine months of 2020 included payments on long-term debt, changes in short-term notes payable and transaction financing, debt issuance and other costs, which were partially offset by proceeds from issuance of long-term debt. In addition, Dow Inc. included cash outflows for dividends paid to stockholders and purchases of treasury stock and TDCC included cash outflows for dividends paid to Dow Inc. Cash used for financing activities from continuing operations in the first nine months of 2019 included payments on long-term debt and dividends paid to DowDuPont, which were partially offset by proceeds from the issuance of long-term debt. In addition, Dow Inc. received cash as part of the separation from DowDuPont, which more than offset dividends paid to common stockholders and repurchases of common stock. TDCC was further impacted by the change in the note payable with Dow Inc. See Note 12 to the Consolidated Financial Statements for additional information related to the issuance and retirement of debt.

Cash used for financing activities from discontinued operations in the first nine months of 2019 primarily related to distributions to noncontrolling interests and employee taxes paid for share-based payment arrangements.

### Dow Inc. Non-GAAP Cash Flow Measures

#### Free Cash Flow

Dow defines free cash flow as cash flows from operating activities - continuing operations, less capital expenditures. Under this definition, free cash flow represents the cash generated by the Company from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represents the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's financial planning process.

#### Operating EBITDA and Pro Forma Operating EBITDA

Dow defines Operating EBITDA (for the three months ended September 30, 2020 and 2019 and the nine months ended September 30, 2020) as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation and amortization, excluding the impact of significant items. Pro forma Operating EBITDA (for the nine months ended September 30, 2019) is defined as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation and amortization, plus pro forma adjustments, excluding the impact of significant items.

#### Cash Flow Conversion (Operating EBITDA or Pro Forma Operating EBITDA to Cash Flow From Operations)

Dow defines cash flow conversion (Operating EBITDA or pro forma Operating EBITDA to cash flow from operations) as cash flows from operating activities - continuing operations, divided by Operating EBITDA or pro forma Operating EBITDA. Management believes cash flow conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings to cash flow.

These financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as alternatives to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, Dow's definitions may not be consistent with the methodologies used by other companies.

*In millions*

| Reconciliation of Free Cash Flow | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 |
| --- | ---: | ---: |
| Cash provided by operating activities - continuing operations (GAAP) | $4,596 | $3,793 |
| Capital expenditures | (955) | (1,384) |
| Free cash flow (non-GAAP) | $3,641 | $2,409 |

*In millions*

| Reconciliation of Cash Flow Conversion (Operating EBITDA or Pro Forma Operating EBITDA to Cash Flow From Operations) | Nine Months Ended Sep 30, 2020 | Sep 30, 2019 1 |
| --- | ---: | ---: |
| Income from continuing operations, net of tax (GAAP) | $40 | $593 |
| + Provision for income taxes on continuing operations | 215 | 356 |
| Income from continuing operations before income taxes | $255 | $949 |
| - Interest income | 27 | 58 |
| + Interest expense and amortization of debt discount | 617 | 711 |
| + Pro forma adjustments ² | — | 65 |
| - Significant items ³ | (816) | (1,652) |
| Operating EBIT (non-GAAP) | $1,661 | $3,319 |
| + Depreciation and amortization | 2,148 | 2,225 |
| Operating EBITDA (non-GAAP) | $3,809 | $5,544 |
| Cash provided by operating activities - continuing operations (GAAP) | $4,596 | $3,793 |
| Cash flow conversion (Operating EBITDA or pro forma Operating EBITDA to cash flow from operations) (non-GAAP) | 120.7% | 68.4% |

1\. Operating EBIT, depreciation and amortization and Operating EBITDA for the nine months ended September 30, 2019 are presented on a pro forma basis.

2\. Pro forma adjustments for the nine months ended September 30, 2019 include: (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont and (2) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs).

3\. The nine months ended September 30, 2020 include integration and separation costs, restructuring and asset related charges - net, a net gain on divestitures, a loss on early extinguishment of debt and a gain related to a legal settlement with Nova. The nine months ended September 30, 2019 include integration and separation costs, environmental charges, restructuring and asset related charges - net, a loss associated with agreements entered into with DuPont and Corteva as part of the separation and distribution, a loss related to previous divestitures, a loss on early extinguishment of debt, a gain on a warranty accrual adjustment of an exited business and a net gain related to litigation matters. See Note 23 to the Consolidated Financial Statements for additional information.

### Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations and the Company's ability to access capital markets is expected to meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, contributions to pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from operating activities, the Company’s current liquidity sources also include TDCC's U.S. and Euromarket commercial paper programs, committed and uncommitted credit facilities, committed accounts receivable facilities, a U.S. retail note program (“InterNotes®”) and other debt markets.

The Company continues to maintain a strong financial position and build further liquidity in the midst of the economic recession triggered by the COVID-19 pandemic. The Company started 2020 with significant committed liquidity facilities. As markets became more volatile and uncertain during the first quarter of 2020, the Company took proactive measures to further bolster liquidity by drawing down certain uncommitted credit facilities, which were subsequently repaid in the second quarter of 2020, and partially monetizing investments in company-owned life insurance policies. At September 30, 2020, the Company had cash and committed and available forms of liquidity in excess of $13.5 billion. The Company also has no substantive long-term debt maturities until the second half of 2024. Additional details on sources of liquidity are as follows:

#### Commercial Paper

TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had no commercial paper outstanding at September 30, 2020 ($151 million at December 31, 2019). TDCC maintains access to the commercial paper market at competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be greater, or less than, the amount reported at the end of the period. Subsequent to September 30, 2020, TDCC issued approximately $1,600 million of commercial paper.

#### Committed Credit Facilities

The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At September 30, 2020, TDCC had total committed and available credit facilities of $7.8 billion. In the first nine months of 2020, Dow Silicones voluntarily repaid $2.0 billion of principal under a certain third party credit agreement. See Note 12 to the Consolidated Financial Statements for additional information on committed and available credit facilities.

#### Committed Accounts Receivable Facilities

In addition to the above committed credit facilities, the Company maintains a committed accounts receivable facility in North America where eligible trade accounts receivable, up to $900 million, may be sold at any point in time. For additional information, see Note 15 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. The Company also maintains a committed accounts receivable facility in Europe where eligible trade accounts receivable, up to €400 million, may be sold at any point in time. See Note 12 to the Consolidated Financial Statements for additional information.

#### Company-Owned Life Insurance

The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date. The Company has the ability to monetize its investment in its COLI policies as an additional source of liquidity. At September 30, 2020, the Company had monetized $296 million of its existing COLI policies' value ($85 million at December 31, 2019). See Note 7 to the Consolidated Financial Statements for additional information.

#### Uncommitted Credit Facilities

Dow has entered into various uncommitted bilateral credit arrangements as a potential source of excess liquidity. These lines can be used to support short-term liquidity needs and for general purposes, including letters of credit. In the first quarter of 2020, the Company took proactive measures to further bolster liquidity by drawing down certain uncommitted credit facilities, which were subsequently repaid in the second quarter of 2020. See Note 12 to the Consolidated Financial Statements for additional information.

#### Debt

As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and cash equivalents" and "Marketable securities." At September 30, 2020, net debt as a percent of total capitalization decreased to 49.7 percent and 48.3 percent for Dow Inc. and TDCC, respectively, compared with 50.9 percent and 49.6 percent at December 31, 2019.

*In millions*

| Total Debt | Dow Inc. Sep 30, 2020 | Dec 31, 2019 | TDCC Sep 30, 2020 | Dec 31, 2019 |
| --- | ---: | ---: | ---: | ---: |
| Notes payable | $329 | $586 | $329 | $586 |
| Long-term debt due within one year | 347 | 435 | 347 | 435 |
| Long-term debt | 16,698 | 15,975 | 16,698 | 15,975 |
| Gross debt | $17,374 | $16,996 | $17,374 | $16,996 |
| - Cash and cash equivalents | 4,549 | 2,367 | 4,549 | 2,367 |
| - Marketable securities 1 | 30 | 21 | 30 | 21 |
| Net debt | $12,795 | $14,608 | $12,795 | $14,608 |
| Total equity | $12,932 | $14,094 | $13,691 | $14,862 |
| Gross debt as a percent of total capitalization | 57.3% | 54.7% | 55.9% | 53.3% |
| Net debt as a percent of total capitalization | 49.7% | 50.9% | 48.3% | 49.6% |

1\. Included in "Other current assets" in the consolidated balance sheets.

In February 2020, the Company issued €2.25 billion aggregate principal amount of notes (“Euro Notes”). The Euro Notes include €1 billion aggregate principal amount of 0.50 percent notes due 2027, €750 million aggregate principal amount of 1.125 percent notes due 2032 and €500 million aggregate principal amount of 1.875 percent notes due 2040. The Euro Notes have a weighted average coupon rate of approximately 1.0 percent. In addition, the Company redeemed $1.25 billion of 3.0 percent notes issued by the Company with maturity in 2022.

In August 2020, the Company issued $2.0 billion aggregate principal amount of notes. The notes included $850 million aggregate principal amount of 2.1 percent notes due 2030 and $1.15 billion aggregate principal amount of 3.6 percent notes due 2050 (together, the "Notes"). In September 2020, TDCC used $556 million of aggregate proceeds from the Notes to fund cash tender offers for certain of its debt securities and certain debt securities of Union Carbide, of which $493 million aggregate principal amount was tendered and retired.

The Company may at any time repurchase certain debt securities in the open market or in privately negotiated transactions subject to: the applicable terms under which any such debt securities were issued, certain internal approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such potential transactions might take place. This in no way obligates the Company to make any such repurchases nor should it be considered an offer to do so.

TDCC's public debt instruments and primary, private credit agreements contain, among other provisions, certain customary restrictive covenant and default provisions. TDCC's most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds $500 million. The ratio of TDCC's consolidated indebtedness to consolidated capitalization as defined in the Revolving Credit Agreement was 0.53 to 1.00 at September 30, 2020. Management believes TDCC was in compliance with all of its covenants and default provisions at September 30, 2020. For information on TDCC's debt covenants and default provisions, see Note 16 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. There were no material changes to the debt covenants and default provisions related to TDCC’s outstanding long-term debt and primary, private credit agreements in the first nine months of 2020.

While taking into consideration the current economic environment, management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

### Credit Ratings

At September 30, 2020, TDCC's credit ratings were as follows:

|  |  |  |  |
| --- | --- | --- | --- |
| **Credit Ratings** | Long-Term Rating | Short-Term Rating | Outlook |
| Standard & Poor’s | BBB- | A-3 | Stable |
| Moody’s Investors Service | Baa2 | P-2 | Stable |
| Fitch Ratings | BBB+ | F2 | Negative |

On April 9, 2020, Standard & Poor's ("S&P") announced a credit rating change for TDCC from BBB and A-2 to BBB- and A-3, maintaining stable outlook. The decision was made as part of S&P’s broader review of the chemicals sector, in light of the global impact of COVID-19 and lower oil prices. On April 13, 2020, Fitch Ratings ("Fitch") re-affirmed TDCC’s BBB+ and F2 rating, and revised its outlook to negative from stable. The decision was made as part of Fitch’s annual review process.

Downgrades in TDCC's credit ratings will increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

### Dividends

#### Dow Inc.

On February 13, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, which was paid on March 13, 2020, to shareholders of record as of February 28, 2020. On April 9, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, which was paid on June 12, 2020, to shareholders of record as of May 29, 2020. On August 13, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, which was paid on September 11, 2020, to shareholders of record as of August 31, 2020. On October 15, 2020, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on December 11, 2020, to shareholders of record as of November 30, 2020.

#### TDCC

Effective with the separation from DowDuPont on April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by Dow Inc.'s Board from time to time, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. For the three months ended September 30, 2020, TDCC declared and paid a dividend to Dow Inc. of $513 million ($1,685 million for the nine months ended September 30, 2020). At September 30, 2020, TDCC's intercompany loan balance with Dow Inc. was insignificant. See Note 22 to the Consolidated Financial Statements for additional information.

### Share Repurchase Program

On April 1, 2019, Dow Inc.'s Board ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3.0 billion to be spent on the repurchase of the Company's common stock, with no expiration date. The Company did not repurchase any of its common stock in the third quarter of 2020 (repurchased $125 million of the Company's common stock in the nine months ended September 30, 2020). At September 30, 2020, approximately $2.4 billion of the share repurchase program authorization remained available for repurchases. At this time, Dow Inc. does not expect to repurchase additional shares in 2020, but will continue to evaluate as the year progresses.

### Pension Plans

The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The Company's funding policy is to contribute to funded plans when pension laws and/or economics either require or encourage funding. The Company expects to contribute approximately $250 million to its pension plans in 2020, of which $188 million has been contributed through September 30, 2020. See Note 17 to the Consolidated Financial Statements and Note 21 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019 for additional information concerning the Company's pension plans.

### Restructuring

The actions related to the 2020 Restructuring Program are expected to result in additional cash expenditures of approximately $380 million, primarily through the first quarter of 2022, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including contract cancellation penalties and environmental remediation. Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, are expected to result in additional cash expenditures of approximately $150 million, primarily through the third quarter of 2022. The activities related to the Synergy Program are expected to result in additional cash expenditures of approximately $50 million, primarily through the end of 2020, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation.

The Company expects to incur additional costs in the future related to its restructuring activities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits related to its other optimization activities. These costs cannot be reasonably estimated at this time. See Note 6 to the Consolidated Financial Statements for additional information on the Company's restructuring activities.

### Integration and Separation Costs

Integration and separation costs related to business separation activities are expected to result in additional cash expenditures of $50 million to $65 million through the end of 2020.

### Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in Notes 16, 17, 18 and 21 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. With the exception of the items noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2019.

*In millions*

| Contractual Obligations at Sep 30, 2020 | Payments Due In 2020 | 2021-2022 | 2023-2024 | 2025 and beyond | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Long-term debt obligations 1 | $101 | $770 | $1,490 | $15,059 | $17,420 |
| Expected cash requirements for interest 2 | $193 | $1,534 | $1,418 | $8,995 | $12,140 |
| Operating leases 3 | $127 | $802 | $510 | $806 | $2,245 |

1\. Excludes unamortized debt discount and issuance costs of $375 million. Includes finance lease obligations of $496 million.

2\. Cash requirements for interest on long-term debt was calculated using current interest rates and exchange rates at September 30, 2020, and includes $363 million of various floating rate notes.

3\. Includes imputed interest of $352 million.

### Off-Balance Sheet Arrangements

Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate these entities (see Note 21 to the Consolidated Financial Statements).

Guarantees arise during the ordinary course of business from relationships with customers, committed accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others if specific triggering events occur. The Company had outstanding guarantees at September 30, 2020 of $3,788 million, down from $3,952 million at December 31, 2019. Additional information related to guarantees can be found in the "Guarantees" section of Note 13 to the Consolidated Financial Statements.

### Fair Value Measurements

See Note 20 to the Consolidated Financial Statements for additional information concerning fair value measurements.

### OTHER MATTERS

### Recent Accounting Guidance

See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

### Critical Accounting Estimates

The preparation of financial statements and related disclosures in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019 ("2019 10-K") describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. The Company’s accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the 2019 10-K. Since

December 31, 2019, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates.

### Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants:

| Asbestos-Related Claim Activity | 2020 | 2019 |
| --- | ---: | ---: |
| Claims unresolved at Jan 1 | 11,117 | 12,780 |
| Claims filed | 3,623 | 4,396 |
| Claims settled, dismissed or otherwise resolved | (5,099) | (5,763) |
| Claims unresolved at Sep 30 | 9,641 | 11,413 |
| Claimants with claims against both Union Carbide and Amchem | (3,168) | (3,935) |
| Individual claimants at Sep 30 | 6,473 | 7,478 |

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 13 to the Consolidated Financial Statements and Part II, Item 1. Legal Proceedings.

## Market risk

As filed, 359 characters.

See Note 19 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019, for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

## Controls and procedures

As filed, 1,272 characters.

### Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.

### Changes in Internal Control Over Financial Reporting

There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.

### Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries PART II – OTHER INFORMATION

## Risk factors

As filed, 2,758 characters.

Since December 31, 2019, there have been no material changes to the Company's Risk Factors, except as noted below:

**Public Health Crisis: A public health crisis or global outbreak of disease, including the pandemic caused by coronavirus disease 2019 (“COVID-19”) has had, and could continue to have, a negative effect on the Company's manufacturing operations, supply chain and workforce, creating business disruptions that could continue to have a substantial negative impact on the Company’s results of operations, financial condition and cash flows.**

The pandemic caused by COVID-19 has impacted all geographic regions where Dow products are produced and sold. The global, regional and local spread of COVID-19 has resulted in significant global mitigation measures, including government-directed quarantines, social distancing and shelter-in-place mandates, travel restrictions and/or bans, and restricted access to certain corporate facilities and manufacturing sites. Uncertainty with respect to the severity and duration of the COVID-19 pandemic, coupled with oil price fluctuations due in part to the global spread of COVID-19 and the continued increase in global cases, has contributed to the volatility of financial markets. While the severity and duration of the COVID-19 pandemic in key geographic regions and end-markets cannot be reasonably estimated at this time, impacts to the Company include, but are not limited to: fluctuations in the Company’s stock price due to market volatility; a decrease in demand for certain Company products; price declines; reduced profitability; supply chain disruptions impeding the Company’s ability to ship and/or receive product; temporary idling or permanent closure of select manufacturing facilities and/or manufacturing assets; asset impairment charges; interruptions or limitations to manufacturing operations imposed by local, state or federal governments; reduced market liquidity and increased borrowing costs; workforce absenteeism and distraction; labor shortages; customer credit concerns; increased cyber security risk and data accessibility disruptions due to remote working arrangements; workforce reductions and fluctuations in foreign currency markets. Additional risks may include, but are not limited to: shortages of key raw materials; potential impairment in the carrying value of goodwill; additional asset impairment charges; increased obligations related to the Company’s pension and other postretirement benefit plans; and deferred tax valuation allowances. Business disruptions and market volatility resulting from the COVID-19 pandemic have had and could continue to have a substantial negative impact on the Company’s results of operations, financial condition and cash flows.

Filed Oct 23, 2020.
Source: SEC EDGAR, the filing index for accession 0001751788-20-000034. Last ingested by Listed: Nov 2, 2026, 16:51 ET. No prices; not investment advice.
